Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Event Details


MSc in Nanotechnology for Medicine and Health Care

Add this event to your calendar: iCal   Google Calendar

Who should attend?

The University of Oxford MSc in Nanotechnology for Medicine and Health Care is a part-time, modular course leading to a postgraduate qualification at the University of Oxford. The course is designed for students wishing to study part-time. It will appeal to those working in the commercial, research or healthcare sectors who use or develop nanotechnology in their work. Applications are welcome from biomedical engineers, materials scientists, biotech-entrepreneurs, medical practitioners, chemists, pharmacists, electrical engineers, project managers in related industries, patent agents, legislators, as well as those involved in commercial or academic research in this area of science.


Nanotechnology is becoming an increasing driving force behind innovation in medicine and modern healthcare, with a range of advances including nanoscale therapeutics, biosensors, implantable devices and imaging systems. However, the pace with which this revolution is occurring has left even some of its leading practitioners lacking in aspects of the key fundamental knowledge or the information required to navigate the regulatory and clinical pathway to achieve market realization.

The University of Oxford’s MSc in Nanotechnology for Medicine and Health Care builds on the University’s world-leading research in nanomedicine and offers a cutting-edge education in this field.

The course will examine how nanoparticles offer a new platform for drug delivery that can extend the “patent life” of drugs, how nanotechnology is providing the basis for many of the new regenerative medicine approaches based on artificial scaffold structures and how it offers solutions for many of the new generation of point-of-care biosensors and some of the advanced gene sequencing instrumentation.

The course is specifically designed to be taken part-time as a mixture of online and face-to-face modules, meaning it can fit around the demands of those working full-time and can be studied by international students without the requirement to relocate.

The course comprises:

  • three online modules giving a thorough introduction to the fundamental science of nanotechnology and the behaviour and characterisation of nanoscale materials;

  • three five-day modules taught face-to-face in Oxford explaining the scientific, regulatory, clinical and commercial aspects of the application of nanotechnology to medicine and healthcare

  • an original research project of approximately 18 weeks to be written up as a dissertation

The three online modules can be taken from anywhere in the world with tutors who provide online support and electronically replicate the famed Oxford tutorial system, whereas the three face-to-face modules offer intense, focused lectures from Oxford academics from a range of disciplines with expertise in this field. Assessment throughout the modules ensures that students can monitor their progress.  The course is supported by a virtual learning environment (VLE).


  • Module 1: The Wider Context of Nanotechnology (online)

  • Module 2: The Fundamental Science of Nanotechnology (online)

  • Module 3: Fundamental Characterisation for Nanotechnology (online with two-day component in Oxford)

  • Module 4: Introduction to Bionanotechnology (in Oxford)

  • Module 5: Nanomedicine – Science and Applications (in Oxford)

  • Module 6: Clinical Translation and Commercialisation of Nanomedicine (in Oxford)



Course Administrator

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.